Open original FDA record ↗Recall record
- FDA identifier
- Z-1204-2019
- Company in FDA record
- Siemens Medical Solutions USA, Inc
- FDA record creation date
- Apr 19, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Advisory issued not to disable or bypass the AMP function. Disabling or bypassing the AMP function for reasons of comfort is not advisable may lead to patient or user injury due to collision with LINAC equipment disabling the Auto Field Sequence (AFS) Automatic Motion Protection (AMP) function implemented at the control of the Digital Linear Accelerator.
Source facts
- Action
- Siemens Healthcare issued CUSTOMER SAFETY ADVISORY NOTICE to accounts via electronic mail addresses and/or USPS certified mail on March 20. Letter identifies the issue , action to take: due to potential for collisions of the LINAC equipment with patients, Siemens Healthcare GmbH advises customers to not to disable or bypass the AMP function. Customers who decide to disable or bypass the AMP function, do so at their own responsibility, duly weighing patient benefit and risk. Disabling or bypassing for reasons of comfort is not advisable. Notify and instruct accordingly all the staff at your organization who need to be aware of this notice. In addition, if you may have further distributed this product, please identify your customers and notify them. Only in the event you choose to disable or bypass the AMP Function, Siemens requests that you carefully read and complete the following form. Please sign, scan, and email the completed form mail to:csslmro.team@siemens-healthineers.com
- Initiated
- 2019-03-20
- Root cause
- Use error
- Terminated
- 2020-06-18
- Distribution
- Nationwide
- Recall number
- Z-1204-2019
- Recall status
- Terminated
- CDRH record ID
- 172025
- FDA record created
- 2019-04-19
- Recall event number
- 82605